These were the biggest pharmaceutical deals in early 2022
Por um escritor misterioso
Descrição
GlobalData tracks the latest acquisitions, mergers, venture financing and asset transactions in the pharmaceutical sector.
Biopharma M&A: Year in Review, Ripples Ahead
Betaville Alert] MKT Tactical Fund (a 4.6% stakeholder in AUPH) appoints a lawyer to manage an action group to persuade the AUPH Board Of Directors to initiate a strategic review. Also stated
Trends in biopharma M&A: seeking value - IQVIA
July 2022 Price Hikes Report Patients For Affordable Drugs
Top 20 BioPharma Companies based on 2022 Total Revenue
Top companies and drugs by sales in 2022
Pharmaceutical market worldwide revenue 2001-2022
Top 20 Biopharma M&A of 2022 by Total Deal Value
Drug Channels: Drug Channels News Roundup, December 2022: Vertical Integration Updated, Walgreens vs. Pharmacy, Cash-Pay Rx, Curing 340B, and Deductible Season
Pharmaceuticals Industry Deals and Trends in November 2022 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
COVID-19 treatment Paxlovid has been free so far. Next year, sticker shock awaits
Pipelinepharma
Process Analytical Technology Market Revenue Trends and Growth Drivers
Drug Channels: The Top 15 U.S. Pharmacies of 2022: Market Shares and Revenues at the Biggest Companies
U.S. new drug price exceeds $200,000 median in 2022
